Skip to content

RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

RT-PCR on Conjunctival Sample for the Detection of SARS-Cov-2 in Patients With Covid-19

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04397666
Acronym
P20/09
Enrollment
68
Registered
2020-05-21
Start date
2020-05-15
Completion date
2021-12-15
Last updated
2021-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pinkeye, SARS-CoV Infection

Brief summary

the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients

Interventions

DIAGNOSTIC_TESTconjunctival RT PCR

conjunctival sample in covid-19 patients

Sponsors

Versailles Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and Women positive for SARS-Cov-2 on a RT-PCR test of a sample of respiratory airway * Persons over 18 years of age * patients of both sexes * Member of a social security scheme * Having signed the consent form

Exclusion criteria

* Minors not emancipated, persons out of state to express their consent * Participation in intervention research on Covid-19 involving experimental treatment * History of chronic disease conjunctiva * Patient with one of the one of the criteria of following gravity: 1. EN \> or =30/min, 2. Pao2/Fio2 = or \< 300, 3. confusion and/or disorientation, 4. hypotension (Tas90mmhg, requiring aggressive filling), 5. need for a invasive ventilation, 6. septic shock

Design outcomes

Primary

MeasureTime frameDescription
the SARS-Cov-2 positivity rate in patients with Covid-19 with or without signs of conjunctivitis3 monthsto assess the SARS-Cov-2 positivity rate in patients with Covid-19 with or without signs of conjunctivitis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026